Skip to main content
OpenTrials
Completed

NCT Number: NCT02456636

Rural Engagement in Primary Care for Optimizing Weight Reduction

The purpose of this study is to compare three methods for managing obesity in rural patients, to see which method will result in patients being able to attain their weight loss goal and maintain that weight loss.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

About this study

Nearly 20% of the U.S. population lives in rural communities. Rural residents suffer at a higher rate from obesity and obesity-related illnesses, including diabetes, heart disease, and arthritis. Local primary care physicians are an important resource for treating obesity in rural areas because of a lack of other community resources.

This study is looking at how effective current, real-world primary care treatment models are in helping rural residents lose weight and maintain that weight loss. Physician clinics will be randomized (like picking numbers from a hat) to conduct one of the three methods. The method a participant is part of will depend on the method their physician's clinic is randomized to. The three methods involved in this study are:

  • Individual weight-management counseling in person (in clinic individual visits)
  • Group weight-management counseling, both in person and by telephone; the latter if preferred by the group (in clinic group visits)
  • Group weight-management counseling by telephone (phone group visits)

Participants will be in the study about 24 months. The number of in-person clinic visits and phone calls each participant will be asked to complete depends on the method.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI between 30 kg/m2 and 45 kg/m2.
  • Live in a rural location.
  • Have clearance from their primary care provider to participate in a diet and exercise weight control intervention.
  • Have access to a telephone.
  • One individual per household will be permitted to enroll in the study.

Exclusion criteria

  • History of heart attack in the last six months, stroke in the last six months, or new cancer diagnosis in the last six months.
  • History of bariatric surgery or planning bariatric surgery in the next two years.
  • Pregnancy within the last six months or planned within the next two years or currently pregnant or lactating.
  • Serious medical conditions where weight loss is contraindicated.
  • End stage renal disease or end stage liver disease.
  • Other medical contraindications as determined by the patient's primary care physician (PCP); documented PCP clearance will be obtained.
  • Participants who are already enrolled in, or planning to enroll in another research study where weight loss is targeted.
  • Participants who plan to relocate outside of their provider's service area or who plan to leave their primary care clinic in the next 2 years.
  • Unable to read and understand English.

Treatment and study plan

Fee-for-Service Model (FFS, In clinic individual visits)

Behavioral

To be performed by participant's doctor or other healthcare professional in their doctor's office.

Other names: Individual weight management counseling

Patient Centered Medical Home (PCMH, In clinic group visits)

Behavioral

To be performed by a registered dietitian, a nurse or other healthcare professional in their local setting.

Other names: Group weight management counseling (in-person and telephone)

Disease Management (DM, Phone group visits)

Behavioral

To be performed by obesity treatment specialists with relevant graduate training and experience with weight loss counseling via telephone.

Other names: Group weight management counseling (telephone)

Primary outcomes

  1. Mean Weight Change Over 24 Months; Unadjusted Except for Affiliation

    Time frame: Baseline and 6, 18 and 24 months

    Mean weight change (kg) of participants between the three study groups. Weight loss at 24 months, and all relevant study visits in between, will be compared 1) between PCMH (in clinic group visits) versus FFS (in clinic individual visits), 2) between DM (phone group visits) versus FFS (in clinic individual visits), and 3) between PCMH (in clinic group visits) versus DM (phone group visits). Unadjusted except for affiliation.

  2. Mean Weight Change Over 24 Months; Adjusted

    Time frame: Baseline and 6, 18 and 24 months

    Mean weight change (kg) of participants between the three study groups. Weight loss at 24 months, and all relevant study visits in between, will be compared 1) between PCMH (in clinic group visits) versus FFS (in clinic individual visits), 2) between DM (phone group visits) versus FFS (in clinic individual visits), and 3) between PCMH (in clinic group visits) versus DM (phone group visits). Adjusted for affiliation, sex, race/ethnicity, education, diabetes, cardiovascular disease, and travel time to clinic.

Secondary outcomes

  1. Mean Percent Weight Loss Over 24 Months; Unadjusted Except for Affiliation

    Time frame: Baseline and 6, 18 and 24 months

    Comparison in percent weight loss from baseline of participants between the three study groups. Weight loss at 24 months, and all relevant study visits in between, will be compared 1) between PCMH (in clinic group visits) versus FFS (in clinic individual visits), 2) between DM (phone group visits) versus FFS (in clinic individual visits), and 3) between PCMH (in clinic group visits) versus DM (phone group visits). Unadjusted except for affiliation.

  2. Mean Change in Systolic Blood Pressure; Unadjusted Except for Affiliation

    Time frame: Baseline and 6, 18 and 24 months

    Mean change in systolic blood pressure will be compared across all treatment arms; unadjusted except for affiliation.

  3. Mean Change in Diastolic Blood Pressure; Unadjusted Except for Affiliation

    Time frame: Baseline and 6, 18 and 24 months

    Mean change in diastolic blood pressure will be compared across all treatment arms; unadjusted except for affiliation.

  4. Mean Change in Fasting Glucose; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Mean change in fasting glucose will be compared across all treatment arms; unadjusted except for affiliation.

  5. Mean Change in Fasting Cholesterol; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Mean change in fasting cholesterol will be compared across all treatment arms; unadjusted except for affiliation.

  6. Mean Change in Fasting Triglycerides; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Mean change in fasting triglycerides will be compared across all treatment arms; unadjusted except for affiliation.

  7. Mean Change in Fasting Low Density Lipoprotein (LDL); Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Mean change in fasting low density lipoprotein (LDL) will be compared across all treatment arms; unadjusted except for affiliation.

  8. Mean Change in Fasting High Density Lipoprotein (HDL); Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Mean change in fasting high density lipoprotein (HDL) will be compared across all treatment arms; unadjusted except for affiliation.

  9. Mean Change in Physical Quality of Life Score, Measured by SF-12; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Change in physical quality of life score, measured by SF-12. The Short Form Health Survey (SF-12) is a general quality of life measure with mental functioning and physical functioning summary scores. Each is scored from 0 to 100 with higher scores representing better functioning. Measures will be collected at baseline, 6 months and 24 months. Unadjusted Except for Affiliation.

  10. Mean Change in Mental Quality of Life Score, Measured by SF-12; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Mean change in mental quality of life score, measured by SF-12. The Short Form Health Survey (SF-12) is a general quality of life measure with mental functioning and physical functioning summary scores. Each is scored from 0 to 100 with higher scores representing better functioning. Measures will be collected at baseline, 6 months and 24 months. Unadjusted Except for Affiliation.

  11. Mean Change in Total Quality of Life Score Measured by IWQOL-L; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    The Impact of Weight on Quality of Life-Lite (IWQOL-L) measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life. Measures will be collected at baseline, 6 months and 24 months. Unadjusted Except for Affiliation.

  12. Mean Change in Quality of Sleep Score Measured by PSQI; Unadjusted Except for Affiliation

    Time frame: Baseline and 6 and 24 months

    Measured using the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 (better) to 21 (worse). Measures will be collected at baseline, 6 months and 24 months. Unadjusted Except for Affiliation.

  13. Mean Change in Stress Measured by PSS; Unadjusted Except for Affiliation

    Time frame: Baseline and 6, 18 and 24 months

    Mean change in stress measured using the Perceived Stress Scale (PSS). Scores range from 0 to 40. Higher numbers represent greater levels of stress. Measures will be collected at baseline, 6 months, 18 months and 24 months. Unadjusted except for affiliation.

Sponsors and collaborators

Lead sponsor

University of Kansas Medical Center

Other

Collaborators

  • Patient-Centered Outcomes Research Institute

Registry information

Official study title

Rural Engagement in Primary Care for Optimizing Weight Reduction (RE-POWER)

Acronym: RE-POWER

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
May 28, 2015
Registry last updated
Dec 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.